Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)

CUSIP: 15117B202

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
80,000,000
Total 13F shares
32,156,087
Share change
+4,354,617
Total reported value
$476,873,776
Put/Call ratio
41%
Price per share
$14.83
Number of holders
82
Value change
+$67,764,471
Number of buys
54
Number of sells
29

Security key

15117B202

Report period

Q3 2020

Institutions

82

Top holders

10

Top shareholders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BVF INC/IL
13F
Company
3.4%
2,740,000
$35,620,000 30 Jun 2020
13F
RTW INVESTMENTS, LP
13F
Company
3.3%
2,610,000
$33,930,000 30 Jun 2020
13F
Logos Global Management LP
13F
Company
2.5%
2,000,000
$26,000,000 30 Jun 2020
13F
Redmile Group, LLC
13F
Company
2.5%
2,000,000
$26,000,000 30 Jun 2020
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
2.2%
1,750,000
$22,750,000 30 Jun 2020
13F
Ikarian Capital, LLC
13F
Company
2.1%
1,647,439
$21,417,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2%
1,637,175
$21,283,000 30 Jun 2020
13F
Vivo Capital, LLC
13F
Company
2%
1,600,000
$20,800,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
1.6%
1,296,206
$16,851,000 30 Jun 2020
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
1.4%
1,150,000
$14,950,000 30 Jun 2020
13F
Opaleye Management Inc.
13F
Company
1.3%
1,071,000
$13,923,000 30 Jun 2020
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
1.2%
1,000,000
$13,000,000 30 Jun 2020
13F
Boxer Capital, LLC
13F
Company
1.2%
1,000,000
$13,000,000 30 Jun 2020
13F
Eversept Partners, LP
13F
Company
0.89%
712,698
$9,265,074 30 Jun 2020
13F
ORBIMED ADVISORS LLC
13F
Company
0.78%
625,000
$8,125,000 30 Jun 2020
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.58%
463,335
$6,023,000 30 Jun 2020
13F
Corriente Advisors, LLC
13F
Company
0.58%
460,000
$5,980,000 30 Jun 2020
13F
Cresset Asset Management, LLC
13F
Company
0.57%
457,666
$5,950,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.54%
430,564
$5,597,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
0.52%
412,429
$5,362,000 30 Jun 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.38%
306,723
$3,987,000 30 Jun 2020
13F
Monashee Investment Management LLC
13F
Company
0.38%
300,000
$3,900,000 30 Jun 2020
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.31%
250,100
$3,251,000 30 Jun 2020
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.29%
228,015
$2,964,000 30 Jun 2020
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.26%
208,836
$2,715,000 30 Jun 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.16%
131,094
$1,704,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.16%
130,237
$1,693,000 30 Jun 2020
13F
Granite Point Capital Management, L.P.
13F
Company
0.14%
109,095
$1,418,000 30 Jun 2020
13F
SABBY MANAGEMENT, LLC
13F
Company
0.09%
73,094
$950,000 30 Jun 2020
13F
Informed Momentum Co LLC
13F
Company
0.09%
69,126
$899,000 30 Jun 2020
13F
SIMPLEX TRADING, LLC
13F
Company
0.08%
62,592
$813,000 30 Jun 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.07%
59,508
$774,000 30 Jun 2020
13F
ExodusPoint Capital Management, LP
13F
Company
0.07%
58,415
$759,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.07%
57,300
$744,000 30 Jun 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.07%
56,056
$729,000 30 Jun 2020
13F
CIBC WORLD MARKET INC.
13F
Company
0.05%
40,000
$520,000 30 Jun 2020
13F
Qube Research & Technologies Ltd
13F
Company
0.05%
36,334
$472,000 30 Jun 2020
13F
Creative Planning
13F
Company
0.04%
35,347
$460,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
0.03%
23,142
$301,000 30 Jun 2020
13F
WINTON GROUP Ltd
13F
Company
0.02%
19,401
$252,000 30 Jun 2020
13F
Mirador Capital Partners LP
13F
Company
0.02%
19,134
$249,000 30 Jun 2020
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.02%
15,400
$200,000 30 Jun 2020
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
13,876
$180,000 30 Jun 2020
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.02%
13,863
$180,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.02%
12,026
$156,000 30 Jun 2020
13F
Tekla Capital Management LLC
13F
Company
0.01%
7,053
$92,000 30 Jun 2020
13F
Walleye Trading LLC
13F
Company
0.01%
5,714
$74,000 30 Jun 2020
13F
Skandinaviska Enskilda Banken AB (publ)
13F
Company
0%
3,333
$43,000 30 Jun 2020
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0%
1,774
$23,000 30 Jun 2020
13F
Lindbrook Capital, LLC
13F
Company
0%
1,618
$21,000 30 Jun 2020
13F

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) as of Q3 2020

As of 30 Sep 2020, Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,156,087 shares. The largest 10 holders included RTW INVESTMENTS, LP, BVF INC/IL, ADAGE CAPITAL PARTNERS GP, L.L.C., Redmile Group, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Vivo Capital, LLC, ACUTA CAPITAL PARTNERS, LLC, Ikarian Capital, LLC, and Polar Capital LLP. This page lists 82 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
63
Q3 2020 holders
82
Holder diff
19
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .